AI assistant
Anteris Technologies Global Corp. — Capital/Financing Update 2018
Dec 3, 2018
33869_rns_2018-12-03_b6ebd37e-60ef-4648-816c-0d7472a5540c.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
4.12.2018
==> picture [451 x 24] intentionally omitted <==
ASX ANNOUNCEMENT
ASX Market Announcements Australian Securities Exchange Limited 20 Bridge Street SYDNEY NSW 2000
Admedus Limited (ASX:AHZ)
DESPATCH OF LETTERS TO ELIGIBLE AND INELIGIBLE SHAREHOLDERS
Admedus Limited ( Admedus ) advises that letters were despatched to shareholders on 28 November 2018 via post and on 29 November 2018 via email advising them whether they have been determined to be eligible or ineligible to participate in the renounceable pro-rata entitlement offer ( Entitlement Offer ) announced to ASX on Wednesday, 28 November 2018.
A template copy of the letters sent to shareholders are attached.
The Entitlement Offer opens today, Tuesday, 4 December 2018, and is scheduled to close at 5:00 pm (AEDT) on Thursday, 13 December 2018.
If you are an eligible shareholder and do not receive a copy of the prospectus or have any questions in relation to your entitlement under the Entitlement Offer, please contact the Share Registry, Computershare, via the details listed below.
Shareholders should also note that trading in Admedus’ rights in relation to the Entitlement Offer (ASX: AHZRA) is currently underway and will end on Thursday, 6 December 2018.
ENDS
Admedus Limited
T: 1300 550 310 F: 1300 880 398 International: T: +61 (0)7 3152 3200 F: +61 (0)7 3152 3299 E: [email protected] W: admedus.com
==> picture [72 x 72] intentionally omitted <==
Registered Office: Level 9, 301 Coronation Drive, Milton, Queensland 4064
Customer Service:
Brisbane • Minneapolis • Geneva • Singapore AUI-930502815v1
ABN 35 088 221 078
==> picture [451 x 24] intentionally omitted <==
About Admedus Limited
Admedus (ASX:AHZ) is a medical technologies company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Our focus is on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow product and service offerings and expanding revenues from our existing medical sales and distribution business. The company has assets from research & development through clinical development as well as sales, marketing and distribution.
Website: www.admedus.com
Facebook: www.facebook.com/Admedus
Twitter: @Admedus
For more information, please contact:
Share Registry
Computershare Investor Services Pty Ltd Telephone: 1300 557 010 (within Aust) +61 3 9415 4000 (outside Aust) Facsimile: +61 3 9473 2500
Investor Relations
Kyahn Williamson WE Buchan [email protected] 03 9866 4722
AUI-930502815v1
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [7 x 32] intentionally omitted <==
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
AHZ
MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030
2 9 N o v e m b er 20 1 8
D e ar S h ar e holder,
RENOUNCEABLE ENTITLEMENT OFFER – NOTICE TO ELIGIBLE SHAREHOLDERS
A d m e d u s L i m ite d A C N 0 8 8 2 2 1 078 ( Admedus o r Company ) anno u nced o n W e d ne s d a y, 28 N o v e m b er 20 1 8 t ha t it i s u nd e rt a ki n g a r e no u n c eable pr o -r a ta en t itlement o ff e r ( Entitlement Offer ) to raise up to $2 0 .2 mi l lio n , b ef o re c o s ts. T h e p ro c e e ds of t he E n titl e m e nt Of f er w ill pr o vi d e f un d s f or A d m e d u s to:
-
re p ay th e e x is t in g lo a n from S tar B rig h t H ol d in g L imite d ( Star Bright ) to th e a m o u nt of $5 millio n pl u s a n y a c cr u ed int e r e st;
-
• m e et c er t ai n restr u ct u ri n g c os t s; • fu n d re s earc h a nd d ev e lo p m e nt p roj e ct s i ncluding t h e Tr a n s ca t he t er Aortic Valve Replace m e n t ( T A V R ) proje c t; a n d
-
• fu n d g en e ral w o rk i ng ca p it a l a n d o p e ra t io n al c osts.
T h e E n t itlement O ff e r is p art i all y u n d e rw r itt e n f or $9.1 m illion an d commi t m e nt s h a ve been re c ei v ed fr o m ex i sti n g s h a re h ol d er s f o r a fu r th e r $ 4 m ill i on . U p t o a fu r th e r $6.3 m i llion i n u n d e rw r iti n g w ill be p r ovi d e d if A d m e d u s d o es not r a ise a m inim u m of n et $1 2 m illi o n i n c as h u n d e r t h e E nt i tle m e n t O ff e r.
Details of the Entitlement Offer
T h e En t itl e m e nt Of f er is be i ng m a d e und e r a t r an s a c tio n -s p e c ifi c p r os p e c tu s in a c cord a nc e w ith s e cti o n 7 1 3 o f th e Cor p or a tio n s A c t 2 0 01 (C t h) ( Corporations Act ). S h ar e h o ld e rs w h o are e ligibl e to parti c ipate in t h e E ntitle m ent O ff e r a re t ho s e pe r so n s w h o :
-
ar e regis t er e d a s a h o ld e r o f f u lly p a id o rd i na r y s ha r es in th e C o m p a n y a s a t 7:00 p m ( A E D T) on M o nd a y, 3 D e c e m be r 2 0 1 8 ( Record Date ) ;
-
ha v e a r egistere d a d dr e s s o n A d m edus’ s h ar e r e gi s ter th a t i s in A u s tra l ia, N e w Ze a la n d, Hong Kong, Si n g a pore o r t he Philip p in e s t o t he ex t en t A d m e d u s c an m a ke th e o f fe r in th o se jurisdicti o ns in a c c or d ance w it h a p pl i ca b le se c uritie s la w s ;
Samples/000001/000001
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [7 x 32] intentionally omitted <==
-
ar e n o t i n t h e Un i te d S t at e s a nd a r e n ot (in c lu d in g a s no m in e e o r c us t odian ) a c ting f o r t he ac c ount o r b e n efi t of a p er s o n in th e U nit e d St a te s w i th respe c t t o t h ei r shar e s i n A d m ed u s, unles s A d m e d u s h as ot h er w is e d e termine d t h at p e r so n may pa r ticipa t e; a n d
-
• ar e el i gi b le u n d er all ap p lic a bl e s e c u riti e s la w s t o r e ceive an of f er u n d er th e E n titlemen t O f fer wit h o u t any re q uir e m e nt fo r a p ro s p e ct u s o r offe r d o cu m e n t t o be l o dged or regist e re d ,
( Eligible Shareholder ).
Eligi b le Sh a r e holde r s m a y s u bscri b e f or 5 n e w fully paid o rdi n a r y s ha r es ( New Shares ) fo r e v er y 7 o r dinar y s h ar e s h el d o n t h e R e c or d D a te at an issue pri c e o f $ 0. 0 8 p er N e w S h a re . E a ch N e w S h a re in c lu d e s o n e f re e at t ac h in g opti o n ( New Option ) w it h a n e x er c is e p r ice of $0.08 p e r N e w O p ti o n a nd a n e x pi r y dat e of thr e e y e a rs fro m t h e d at e of is s u e .
N e w Shar e s u nd e r the En t itl e m e nt Offer w ill be fully p ai d a n d r an k e q u a lly in a ll r es p e c ts w it h e x ist i ng o r dinar y s h ar e s o n issue. N e w O p tio n s wil l b e li s te d and upon ex e rcise wi l l con v er t in t o f ull y p a id o r dinar y s h ar e s r an k in g e q u a lly in all re s pe c ts wi t h e xi s tin g o r di n ar y s h ar e s on issue when th e New O p ti o n i s e x er c is e d.
Eligibility to participate
Y o u h a v e b een sent this l e tter b e c a us e t h e C o m p a ny belie v es yo u a r e a n E li g ibl e S h a r eh o ld e r. If y ou a r e n ot an Eligible S h a re h ol d er , y o u c a n no t p a rti c ip a te in th e E n title m en t O f fe r . T h e C o mpa n y w ill n o tif y th o s e s h ar e h o ld e rs w h o a r e n ot Eli g ibl e S ha r eholders.
Entitlements
E n titlemen t s i n r e s p ec t o f N e w S h ar e s a n d New O p ti o ns will b e r o u n ded u p t o t he near e st w h o le n u m b er a n d hol d in g s on di f fe r en t r e gi s te r s o r s u b -regis t er s w ill no t b e a ggre g at e d t o cal c ul a te e n titl e m e nts.
E n titlemen t s a re re n ou n c e ab l e a nd th e re f or e if yo u d o not w ish t o t a ke yo u r e nt i tle m e n t y ou m a y s ell al l or part o f y o ur entitl e m e nt on A S X b et w e e n F ri d ay , 3 0 N o v e m b er 20 1 8 a n d T h ur s d a y, 6 D ec e m b er 2 0 18 (i n cl u si v e) or tra n sf e r a ll o r pa r t of y o u r e n titl e m e nt di r ec t ly to a n o th e r p er s o n . T h e re is no g u ar a nt e e t ha t t h er e w i ll b e a li q ui d mar k et in t r aded en t itl e m e nt s . A la c k o f liquidit y may im p a c t y o ur a b ilit y t o s e ll you r e n titl e m e nt s o n t h e A S X a n d t he price y o u may be able t o a c hi e ve.
In th e e v e n t t h at Eli g ible S hare h ol d er s d o n o t t a k e u p all o f th e ir e nt i tle m e n ts in f ull, a sh o rtf a ll f acility w i ll b e a va i la b le t o p ro v id e a n o p p o rtunit y for t h os e E ligible S h ar e holders t ha t h a ve ta k en u p th e ir f ull e n titl e m e nts t o a pp l y f or ad d iti o n a l N e w S h ar e s an d a tta c hi n g Ne w O p t io n s ( Additional Shares ). T h e all o ca t io n o f a n y A d d iti o n a l S ha r es u n de r t h e S h o rtf a ll F a c ilit y w ill b e at th e disc r eti o n o f t he di r ec t or s o f A d m e dus.
Prospectus
T h e C o m p an y w ill send a co p y of th e P ro s pectus, along wi t h a p er s o n ali s e d Enti t le m e n t a nd A c cept a nc e F or m , to all Eligi b le Sh a reholde r s o n Tues d ay, 4 D e c e m b er 2 0 18. A c o p y o f t he P r os p e c tu s h a s b ee n r e le a sed t o t h e A S X a n d lod g e d wi t h A SIC o n W e d n e sd a y, 28 N o ve m b e r 2 018.
F u rt h er de t ail s o f the E ntitle m e n t O ff e r i s i n cl u de d i n t h e P ro s p e ct u s. Eligi b le Sh a reholde r s s ho u ld read th e P ro s p e ct u s ca r efully and i n i ts en t irety be f or e deci d in g w h e th e r t o pa r ticipa t e in t he E n titlemen t O f fer.
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [6 x 32] intentionally omitted <==
Important dates
| Ac tiv ity |
D st ate ate (A d) ED T u nl ess ot he rwi se |
||
| An no unc em en t o f En titl em ent Of fer |
W 2 ed 018 nes da y,2 8N ov em be r |
||
| Lo dg em ent of Pro sp ect us wit hA SIC an dA SX |
W 2 ed 018 nes da y,2 8N ov em be r |
||
| En titl em ent sb egi n tr ad ing on AS Xo nd efe rre ds ett lem en t ba sis |
F rida y, 30 No vem be r2 018 |
||
| Sh are sb eg int o t rad eo na n “ ex- ent itle me nt” bas is |
F rida y, 30 No vem be r2 018 |
||
| Re En co titl rd em Dat ent e fo Of rd fer ete rm inin gE lig ible S har eho lde rs und er the |
7 D :00 ece pm mb on er M 20 ond 18 ay , 3 |
||
| En Ac titl ce em pta ent nce Of Fo fer rm op ss ens ent an to dP Eli ro gib spe leS ctu ha sa reh nd old En ers title me nt and |
T ues da y,4 D ece mb er 201 8 |
||
| Tr adi ng ofE nt itle me nts en ds |
T hur sda y, 6D ec em ber 20 18 |
||
| En titl em ent Of fer clo ses |
5 D :00 ece pm mb on er T 20 hur 18 sda y, 13 |
||
| Iss iss ue ue Da du te nde –a rt llot he me Ent nta itle nd me iss nt ue Off of er Ne wS ha res an dN ew O ptio ns |
M on day , 1 7D ec em ber 20 18 |
||
| No En rm titl alt em rad ent ing Of of fer Ne wS ha res an d New O pti ons is sue du nd er |
T ues da y,1 8 |
D ec em be r 20 18 |
|
| De sp atc ho f ho ld ing sta tem en ts |
W 2 ed 018 nes da y, |
19D ec em be r |
Th i s ti m eta b le i s indicati v e o n ly and subject to cha n ge. Th e dir e ctor s of A dm e du s ma y va r y th e se d ate s su b jec t to t h e L i stin g Ru l es. A n extension of t he C losing D ate w ill d ela y the anti c ipa t ed d ate f or i s sue of t h e N e w S har e s a n d N e w O pti o ns. T he d ire c tors of A dm e dus also res e rve the r ight no t to p roc e ed w ith t he w hol e or p art o f the E n title m en t Off e r a n y ti m e b e for e the allo t me n t an d is s ue o f th e Ne w S h are s an d Ne w O p tion s . In that ev e nt, t he r e lev a nt a ppli c ation m o nie s (wi t hou t int e rest ) will be r etur n ed i n full to a ppli c ant s .
Th e co m m e nce m en t of q uot a tion of N ew S hares and N ew O pti o ns i s su b ject to t h e discre t ion o f A S X. C o olin g off rig h ts do n o t a p ply t o a n in v est m ent in N ew Sh a res and Ne w O p tion s . Y o u c ann o t w i thdr a w y our application o nce it has b een ac c ept e d.
Further information
F o r f urthe r infor m a t io n r e gardi n g th e Entitle m ent O ff e r, p le a s e c o nt a ct A d m e d u s’ sh a re re g is t ry, C o m p ut e rsha r e, o n 13 0 0 5 5 2 2 7 0 ( wit h in A u str a li a ) a n d +6 1 3 9415 40 0 0 ( ou t si d e A u s tra l ia) be t w e en 8.30 a m t o 5 . 00 p m ( A E S T ) M on d a y t o F r id a y d ur i ng th e o ffe r p e ri o d. Alter n ati v el y , c on t ac t y o ur st o c k br o ker, soli c ito r , a c c o un t an t o r ot h er pr o fe s si o nal a d vi s er.
O n b e h a lf o f t h e d ir e ct o rs, I t h ank y o u f or yo u r o ng o in g s u p p or t of Admedu s .
Y o ur s sinc e re l y,
J o hn S e ab e rg C h ai r m a n
Samples/000001/000002/i12
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [6 x 32] intentionally omitted <==
Important information
T h is lett e r is i s su e d b y A d m e d u s . This let t er is n ot a p ro s pe c tu s o r of f ering do c u m e n t u n d e r A us t ral i an la w o r u n d er an y o th e r l a w . It is for in f or m a t ion p u rp o s e s o nl y a n d do e s no t c o n s tit u te an of f er, in v it a tio n o r r e c o m m e n da t io n t o s u b s cri b e f or , r e tai n or pur c ha s e an y e n tit l e m ents o r s e c uri t ies in A d m e d u s i n any j urisdi c ti o n. T his l e tter d o e s n o t con s tit u te fin a n c ial pr o du c t a dv i ce an d doe s n o t a nd w i ll not f or m a n y p a r t o f a n y c on t ra c t f o r t h e a c q uisitio n o f e n titl e men t s or A d med u s s ecuri t ies.
T h is let t er m a y not b e rel e a s ed or distri b ut e d i n t h e U nited S t at e s. T hi s l e tter d o e s n o t c on s tit u te an o ff er to sell, o r t h e s olicit a tio n of a n offe r to b u y, a n y s e curiti e s in t h e Un i te d S t at e s o r t o , o r f o r t he a c co u nt or be n ef i t o f , any pe r so n i n th e U nit e d S t a te s . No a cti o n h a s b e en or wil l b e take n t o re g is t er, q u ali f y o r oth e rwise pe r mi t a p u b lic off e ri n g o f t h e N e w Sha r es in a n y ju r isdicti o n ou t side A us t ral i a a nd N e w Z e al a nd . I n p a rticul a r, th e N e w Sha r es a n d N e w O ption s h av e n ot been, a n d wil l n o t b e, regis t er e d u n d er th e U n it e d S ta t es S e cu r iti e s A ct of 1 9 3 3 ( US Securities Act ) o r the se c uritie s laws o f a n y s tat e or o t he r juris d ict i on of th e U n it e d S ta t es. A c co r di n gl y , t h e e nt i tle m e n ts , N e w Shar e s a nd N e w O p tio n s m a y n o t b e i ss u e d to , p u rc h ased or tra d e d b y , or t a ke n up o r e x e r cis e d by, a n y p er s on in th e Unit e d S tates or any p er s on actin g f o r t h e a c c ou n t o r b en e fit of a p er s on in th e Unit e d S ta t es e x ce p t p ur s u a nt t o a n e xemptio n fr o m , o r in a t r ansa c tio n n o t s ub j ec t to, t h e r e gi s tr a tion r e q u ire m e n ts o f th e U S S ec u rities A c t a n d a p p lic a bl e Unit e d S ta t es st a te s e c uri t ie s la w s.
==> picture [14 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [8 x 32] intentionally omitted <==
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
AHZ
MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030
2 9 N o v e m b er 20 1 8
D e ar S h ar e holder,
RENOUNCEABLE ENTITLEMENT OFFER – NOTICE TO INELIGIBLE SHAREHOLDERS
A d m e d u s L i m ite d A C N 0 8 8 2 2 1 078 ( Admedus o r Company ) anno u nced o n W e d ne s d a y, 28 N o v e m b er 20 1 8 t ha t it i s u nd e rt a ki n g a r e no u n c eable pr o -r a ta en t itlement o ff e r ( Entitlement Offer ) to raise up to $2 0 .2 mi l lio n , b ef o re c o s ts. T h e p ro c e e ds of t he E n titl e m e nt Of f er w ill pr o vi d e f un d s f or A d m e d u s to:
-
re p ay th e e x is t in g lo a n from S tar B rig h t H ol d in g L imite d ( Star Bright ) to th e a m o u nt of $5 millio n pl u s a n y a c cr u ed int e r e st;
-
• m e et c er t ai n restr u ct u ri n g c os t s; • fu n d re s earc h a nd d ev e lo p m e nt p roj e ct s i ncluding t h e Tr a n s ca t he t er Aortic Valve Replace m e n t ( T A V R ) proje c t; a n d
-
• fu n d g en e ral w o rk i ng ca p it a l a n d o p e ra t io n al c osts.
T h e E ntitle m e n t O ff e r i s p a rti a lly unde r writte n f o r $ 9 .1 millio n a n d c o m mitm e nts hav e b e e n re c ei v e d fr o m existi n g s hare h older s fo r a f ur t he r $ 4 milli o n. U p to a f u rther $ 6. 3 m illi o n in u nd e r w riti n g w ill be p r ovi d e d if A d m e d u s d o es not r a ise a m inim u m of n et $1 2 m illi o n i n c as h u n d e r t h e E nt i tle m e n t O ff e r.
Details of the Entitlement Offer
T h e E ntitle m e n t O ff e r i s b e in g mad e u n d e r a tr a ns a ction - sp e ci f ic p ro s p e ct u s i n a c cord a nc e w ith s e cti o n 7 1 3 o f th e Cor p or a tio n s A c t 2 0 01 (C t h) ( Corporations Act ).
U n d e r t h e E ntitle m e n t O ff e r, s h a re h ol d er s th a t a re en t itl e d t o p a rti c ip a te m a y s ub s cribe fo r 5 n e w fully p a id o rdin a ry s h a re s ( New Shares ) fo r e v er y 7 o rdinary s h a re s h e ld o n t he R e co r d D at e a t a n is s u e p r ice of $0.08 pe r N e w Sh a r e . E a c h N e w Shar e in c lu d es one f r ee att a c h in g o p tion ( New Option ) with a n e x er c is e p r ice of $0.08 pe r N e w O p tio n a n d a n e x p iry da t e o f t h re e y e ar s f r o m th e d a te of iss u e.
T h is is a le t te r to inf o r m y o u t h at, a c co r di n g to o ur r ec o rds, y ou d o n o t s a tisfy the eli g ibi l ity cri t eri a t o p a rti c ip a te in the En t itl e m e nt O ff e r.
Samples/000001/000001
==> picture [14 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [8 x 32] intentionally omitted <==
Why am I not eligible to participate in the Entitlement Offer?
-
S h ar e h o ld e rs w h o are e ligibl e to parti c ipate in t h e E ntitle m ent O ff e r a re t ho s e pe r so n s w h o : • ar e regis t er e d a s a h o ld e r o f f u lly p a id o rd i na r y s ha r es in th e C o m p a n y a s a t 7:00 p m ( A E D T) on M o nd a y, 3 D e c e m be r 2 0 1 8 ( Record Date ) ;
-
• ha v e a r e gi s ter e d ad d re s s o n A d m e d u s ’ s h ar e r e gi s ter th a t i s in Austr a li a , New Zealand, Hong Ko n g, Si n g a po r e o r t h e P hilip p in e s t o t h e e xt e nt A d m e d u s c a n m a k e the off e r i n t h os e jurisdicti o ns in a c c or d ance w it h a p pl i ca b le se c uritie s la w s ;
• ar e n o t i n th e U nit e d S t a te s a n d a re no t (i n cluding a s no m in e e o r c u st o di a n) ac t in g for t h e ac c ount o r b en e fit of a per s on in t he U n ite d S t at e s w it h resp e ct t o their s h ar e s i n A d m edus, unles s A d m e d u s h as ot h er w is e d e termine d t h at p e r so n may pa r ticipa t e; a n d • ar e el i gi b le u n d er a ll a p p lic a bl e s e curiti e s law s t o recei v e a n o ff e r u nd e r t he En t itl e m e nt O ff e r wit h o u t any re q uir e m e nt fo r a p ro s p e ct u s o r offe r d o cu m e n t t o be l o dged or regist e re d , ( Eligible Shareholder ). A d m e d u s h as de t er m ined, p u rs u an t to se c ti o n 9 A( 3 ) o f t h e C o r po r ati o n s A c t and Listin g R u le 7. 7 .1 ( a) o f th e A S X Li s tin g R ules, tha t it w o u ld be un r ea s o n ab l e t o m ak e offe r s t o s h ar e h o ld e rs in c ountries o u tsi d e o f A u s tralia, N e w Z e a la n d, H o n g K o n g, Si n ga p o r e a nd th e P h ili p pi n es in c o n ne c ti o n w ith th e E n titlemen t O f fer. This is d u e to th e legal and r e g u lat o ry re q ui r e m en t s i n c o u n tri e s o th e r t h a n A u st r ali a , N e w Z e al a nd, Sing a p o re, H o ng K o ng and t h e P hilip p in e s, a n d th e pot e nti a l cost s t o A d m e d u s o f c o m p ly i ng with t h e s e r e q u irements, c o m p ar e d w it h t h e r e la t iv e ly s m a ll n u m b e r o f s h ar e h o ld e rs in t h o s e c ou n tri e s, th e relati v el y s m a l l n u m b er of exi s ti n g A d m e d us or d in a ry s h a re s they h o ld a n d the r e la t iv e ly l o w va l ue of N e w S hares and N e w O p ti o ns to w hich th o se sh a re h ol d e r s w ou l d othe r wi s e b e e ntitle d to subs c ribe f o r.
U n fo r tu n at e ly, acco r ding t o o u r rec o rd s , y ou do no t s a tis f y t h e e ligibil i ty c rit e ri a for a n E l igi b le S h ar e h o ld e r stat e d a b o ve . Acc o rdingl y , i n c o m p li a nc e w ith se c tion 9A( 3 )( b ) o f the C or p or a ti o ns Ac t a n d A S X L i sti n g R ule 7.7. 1 (b ) , t h is l ett e r i s t o in f or m y ou th a t Admed u s h a s d e ter m i n ed th a t you ar e n o t an E ligibl e S h ar e h o ld e r a n d, th e re f or e , are ineligi b le t o e xerci s e y ou r e n titl e men t to be issue d N e w Sh a r e s a nd New O ption s u n d e r t h e E ntitle m ent O ff e r.
T h e E ntitle m e n t O ff e r i s r e no u n c ea b le an d Eligi b le S h ar e holders w ill be able t o tr a d e their e n titl e m e nts duri n g t he off e r p eriod. H o w e ver, a s you ar e n o t an E ligible S h ar e holder y o u w ill no t b e a b le t o t ra d e y ou r e n titl e m e nts.
What happens to my entitlement?
A d m e d u s h as appli e d t o A SI C f o r t h e a p p ointm e nt of a n o minee ( Nominee ) f o r t h e p ur p o s es of s e cti o n 6 1 5 o f th e Cor p or a tio n s A ct to arr a n g e f or t he sa l e o f t h e e nti t le m e n ts w h i ch would h a ve be e n o ff er e d t o s ha r eholders w h o a re no t Eligi b le S h a re h ol d er s ( Ineligible Shareholders ) h a d s u c h p e rs o ns b e en eli g ible t o p a rti c ip a te in t he Entitl e m e nt Of f er. Th e N o m in e e w ill arr a n g e f or p ro c e e ds of s a le ( if a ny), net o f s ub s cripti o n c osts a nd e x pe n s e s, t o b e s en t p r op o rti o n a lly to e a c h I n eligible S h ar e h o ld e r t h ro u g h A d m e d u s’ s h a re r egist r y.
T h e N o m inee wil l h a ve th e a b so l ut e a n d s ol e di s cr e ti o n t o det e rm i ne th e ti m in g and the pr i ce at w hich the E nti t le m e n ts m a y b e s o ld an d t h e m a n n e r o f a n y s al e . N eit h er A d m e du s n o r t he Nomi n ee wi l l b e s u bj e ct t o a ny lia b ili t y f o r t h e f ail u re to s el l th e E nti t le m e n ts a t a p a rti c ul a r pric e .
You are not required to do anything in response to this letter.
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [8 x 32] intentionally omitted <==
Further information
F o r f u rt h er inf o r m ati o n r egar d in g th e Enti t le m e n t Offe r , p l ea s e c o n ta c t A dmed u s o n A d m e d u s ’ s h ar e regis t ry, C o m p ut e rs h ar e , o n 1 300 5 52 27 0 ( w it h in A u s tr a lia ) a n d + 61 3 9 415 4 00 0 ( o ut s id e A u st r ali a ) b e tw e e n 8.30 a m to 5. 0 0 p m (A E S T ) M o n da y t o F r iday duri n g t he off e r p eriod . Al t er n ativel y , c on t ac t y o ur stock b ro k er, s o lici t or, acco u nt a nt or o th e r p ro f es s io n al ad v is e r.
O n b e h a lf o f t h e D ir e ct o rs, th a n k y o u f o r y our o n g o in g s u pp o rt o f A d m e d us .
Y o ur s sinc e re l y,
J o hn S e ab e rg C h ai r m a n
Samples/000001/000002/i12
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [15 x 32] intentionally omitted <==
==> picture [14 x 32] intentionally omitted <==
==> picture [8 x 32] intentionally omitted <==
Important information
T h is lett e r is i s su e d b y A d m e d u s . T hi s le t ter is n ot a p ro s p e ctus o r o f fering docu m e n t u nd e r A u st r ali a n law or un d er any other l a w. It i s for i n for m a t io n p u rp o s e s only and doe s n o t c on s tit u te an o ff er, in v itatio n o r re c o m m e n d ation to s u b sc r ib e fo r , r e tain or p u rc h a s e a ny en t itl e m e nt s o r secu r ities in Adm e du s i n a n y j u ri s dictio n . T his le t ter do e s n ot co n st i tut e fi n a n ci a l p r oduct advic e a n d d o e s n ot a n d w ill no t fo r m an y p a rt o f a ny co n tr a ct f or th e a c qu i siti o n of e ntitle m e n ts or A d m e d u s s e cu r iti e s.
T h is lett e r m a y n o t b e r e le a s e d o r d ist r ibute d in th e U n it e d S tates. T h is lett e r d oe s n o t c on s tit u te an o ff er to s ell, o r th e s o li c itation of an off e r t o buy, any sec u riti e s in t h e Un i te d S t at e s o r t o , or f o r t h e a c co u nt or be n ef i t o f , a n y p e r so n in th e Unit e d S ta t es . No a cti o n h a s b e en or wil l b e ta k e n to re g ist e r, q u ali f y o r oth e rwise pe r mi t a p u b lic off e ri n g o f t h e N e w Sha r es in a n y ju r isdicti o n o utsid e A us t ralia a nd N e w Ze a la n d. In parti c ular, t h e N e w S ha r es and N e w O p ti o ns ha v e n ot be e n, a n d w ill n ot be, regis t er e d u n d er the U n ite d S tat e s S e c uritie s A c t o f 1 9 3 3 ( US Securities Act ) or th e s e cu r iti e s l a w s o f any s t at e o r ot h er ju r isdicti o n o f t h e Un i te d S t at e s. Ac c or d in g ly , th e entitle m ents m a y n o t b e t a k e n u p a n d t he N e w S h a re s a n d N e w O pti o n s m a y n ot be is s ue d t o , p u rcha s ed or tra d e d b y , or t a ke n u p o r e x er c ised b y, a n y p e rs o n i n t h e U ni t ed St a te s o r a n y p er s on ac t in g for t h e a cc o u n t o r b e nefit o f a p e rs o n in t h e U nited St a te s e x c e pt p u r su a nt to a n e x e m p tio n f r om, o r in a t r ansa c tion not s ub j ec t to, the r e gi s tr a tio n r e quire m e n ts of t he U S S e curiti e s A ct an d applica b le U n ite d S t at e s s tate sec u riti e s la w s.